MLchartDataset catalogue

TBF regimen

Term · Oncology and biomedicine · MLC-T-ONC-016997

A regimen consisting of busulfan, fludarabine and thiotepa that is used as a conditioning regimen for hematopoietic stem cell transplantation (HSCT).

Table 1. Record
IdentifierMLC-T-ONC-016997
FieldOncology and biomedicine
Synonymsbusulfan/fludarabine/thiotepa regimen; busulfan/fludarabine/thiotepa; thiotepa/busulfan/fludarabine; fudarabine/busulfan/thiotepa regimen; thiotepa/busulfan/fludarabine regimen
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-016997",
  "term": "TBF regimen",
  "field": "Oncology and biomedicine",
  "definition": "A regimen consisting of busulfan, fludarabine and thiotepa that is used as a conditioning regimen for hematopoietic stem cell transplantation (HSCT).",
  "synonyms": [
    "busulfan/fludarabine/thiotepa regimen",
    "busulfan/fludarabine/thiotepa",
    "thiotepa/busulfan/fludarabine",
    "fudarabine/busulfan/thiotepa regimen",
    "thiotepa/busulfan/fludarabine regimen"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/tbf-regimen/"
}

Record 16,029 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.